A Study of S6G5T-3 in the Treatment of Acne Vulgaris

NCT03761784 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

424

Enrollment

INDUSTRY

Sponsor class

Conditions

Acne Vulgaris

Interventions

DRUG: S6G5T-3
DRUG: S6G5T-8

Sponsor

Sol-Gel Technologies, Ltd.